Table 4. Comparison of viral load values between gender, age, outcome, and clinical condition.

Demographic data
Parameter		N	Median (IQR1)	p-value
Gender	Male	78	51.40 (8.13–265.31)	0.08
	Female	78	24.63 (4.46–88.29)
Age (months)	0–3	86	51.40 (6.12–152.90)	0.007
	4–6	22	63.09 (32.12–211.67)
	7–12	21	39.29 (2.32–236.91)
	>12	26	7.77 (1.72–36.92)
Outcome	Recovery	130	37.96 (6.72–122.71)	0.02
	Death	7	2.80 (0.04–21.49)
Clinical data
Fever	Yes	121	26.15 (4.33–104.46)	<0.001
	No	27	111.29 (51.80–408.21)
Cough	Yes	144	41.53 (4.86–148.15)	0.59
	No	7	11.52 (7.98–106.29)
Dyspnea	Yes	106	37.96 (3.91–154.88)	0.69
	No	40	42.05 (8.58–120.16)
O2 saturation ≤ 95%	Yes	71	26.41 (3.95–150.65)	0.40
	No	51	50.16 (8.36–196.81)
Respiratory distress	Yes	115	39.29 (4.78–150.13)	0.27
	No	18	75.69 (12.66–214.26)
Days of hospitalization	1–4	20	79.36 (11.10–245.08)	0.20
	5–8	49	39.45 (11.89–176.21)
	>8	54	24.42 (4.08–78.04)
Ventilatory support	No	48	70.24 (11.41–342.96)	0.02
	Yes (total)		22.69
	Yes—noninvasive	65	26.41 (6.26–105.11)	0.35
	Yes—invasive	40	17.31 (3.95–68.70)
Intensive Care	Yes	82	30.01 (4.41–113.44)	0.73
	No	67	39.29 (6.90–154.61)
Days of Intensive Care	1–4	20	34.74 (3.60–226.28)	0.547
	5–8	16	16.27 (2.09–106.22)
	>8	24	36.24 (9.10–106.65)
Days of symptom until collect	0–3	51	36.63 (5.99–220.48)	0.19
	4–6	67	39.98 (7.65–135.24)
	7–9	24	19.98 (0.53–77.39)
	>9	12	10.45 (3.92–50.98)
Subtype	RSV-A	64	57.41	0.03
	RSV-B	76	27.35

¹ IQR: interquartile range.

Statistically significant p-values are highlighted in bold.